Ramon Visits 2 - 3: A 65-year-old man with metabolic syndrome

Curriculum:
Hitting the Sweet Spot in the Primary Care Setting: Treating Patients with Diabetes to Glycemic Goals
Credits:
0.75 AMA PRA Category 1 Credits
Launch Date:
13-Aug-13
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

No Primary Audience Was Provided.

Relevant Terms:

No Primary Audience Was Provided.

Anne Peters, MD

Anne Peters, MD
Professor of Medicine
Keck School of Medicine of the University of Southern California
Division of Endocrinology
Director of the USC Clinical Diabetes Programs
Los Angeles, CA

Anne L. Peters, MD, is currently a professor at the Keck School of Medicine of the University of Southern California and the Director of the USC Clinical Diabetes Programs. She runs diabetes centers in Beverly Hills and in underserved East Los Angeles and works with the LA County Department of Health Services on a county-wide diabetes program.
 
Dr. Peters earned her undergraduate degree from Wesleyan University located in Middletown, Conn. and her medical degree from the Pritzker School of Medicine at the University of Chicago. She performed her internal medicine residency at Stanford University Medical Center and fellowship in endocrinology at Cedars-Sinai Medical Center. She was in charge of the clinical diabetes programs at Cedars and then at UCLA before moving to USC.
 
Dr. Peters has been a principal investigator on multiple clinical trials focusing on diabetes and diabetes prevention. She established the Community Diabetes Initiatives Research Center in collaboration with Childrens Hospital Los Angeles with funding from the Keck Foundation, the JDRF, ADA, Rose Hills Foundation, California Nutrition Network and Helmsley Trust. Dr. Peters is a Principal Investigator for the NIH Look AHEAD Study and the UCLA/USC NIH P50 program project, "Family and Neighborhood Interventions to Reduce Heart Disease Risk in East L.A." 
 
She has been an invited speaker at many local, national and international medical conferences. Dr. Peters has authored three books on diabetes and over 100 articles appearing in peer-reviewed medical journals including JAMA, Annals of Internal Medicine, Archives of Internal Medicine, Diabetes Care and the American Journal of Medicine. She serves on the ABIM Endocrine Board and the Board of the ADA. Dr. Peters received the ADA Outstanding Physician Clinician Award in 2008 and the 2010 Bernardo Houssay Award from the National Minority Quality Forum for her work with the underserved. She is an author of the "ADA/EASD Position Statement on the Management of Hyperglycemia in Type 2 Diabetes" and co-chair of the ADA Working Group on the Treatment of Type 1 Diabetes.

Louis Kuritzky, MD

Louis Kuritzky, MD
Assistant Professor
Department of Medicine – Community Health and Family Medicine
University of Florida
Gainesville, FL

Louis Kuritzky, MD, is a Family Physician affiliated with the University of Florida, Department of Community Health and Family Medicine as a Clinical Assistant Professor. Dr. Kuritzky received his medical degree from the Medical College of Virginia, and completed his internship at Miami Valley Hospital, Dayton, Ohio.
 
Prior to joining the faculty at the University of Florida in 1983, where he continues his academic affiliation, Dr. Kuritzky had been a member of the UCLA Family Medicine Clinical Faculty. His current professional society participation includes the American Society of Hypertension (ASH), the American Diabetes Association (ADA), and the American Academy of Family Physicians (AAFP). Dr. Kuritzky has received certification as Specialist in Hypertension by ASH, in addition to being board certified in family medicine by the American Board of Family Medicine.
 
Dr. Kuritzky has spent the majority of his career as an educator, and given numerous presentations, including local, national, and international meetings of professional societies. He is on the editorial boards of Internal Medicine Alert, International Journal of Impotence Research, and Primary Care Special Edition. He has also written numerous textbook chapters and contributed over 100 publications to the literature on diverse topics in journals including Comprehensive Therapy, Hospital Practice, Patient Care, JAMA, and New England Journal of Medicine.

Silvio E. Inzucchi, MD

Silvio E. Inzucchi, MD
Professor of Medicine
Yale University School of Medicine
Department of Endocrinology and Metabolism
Director, Yale Diabetes Center
New Haven, CT

Dr. Inzucchi received his undergraduate degree from Fordham University in New York and his medical degree from Harvard Medical School in Boston. He was an intern and resident in Internal Medicine at Yale-New Haven Hospital and completed his fellowship in Endocrinology & Metabolism at Yale School of Medicine. Dr. Inzucchi is currently Professor of Medicine at Yale, where he serves as Clinical Chief and Fellowship Program Director in the Section of Endocrinology and Director of the Yale Diabetes Center. He has published more than 350 articles, chapters, monographs and abstracts, most focusing on the clinical diabetes care and is a frequently invited lecturer both nationally and internationally. Dr. Inzucchi's research interests include pharmacological management of Type 2 diabetes, the link between diabetes, insulin resistance and cardiovascular diseases, and the inpatient management of hyperglycemia. He recently co-chaired the American Diabetes Association / European Association for the Study of Diabetes committee that authored the Position Statement on anti-hyperglycemic therapy in type 2 diabetes.
1. Develop stepwise treatment plans to attain glycemic goals and manage microvascular complications
2. Employ 2013 ADA Standards of Care to individualize treatment plans for older patients with diabetes in order to improve glycemic control
3. Incorporate rational use of new diabetic pharmacotherapy with more established therapies in order to address the individual needs of patients with diabetes
4. Reduce clinical inertia by intensifying therapy for patients who are not at their glycemic goal, as recommended by 2013 ADA Standards of Care
5. Incorporate additional considerations when developing treatment plans for patients with diabetes in order to improve long-term outcomes